Allergan Stock Analysis, Valuation (NYSE:AGN)

Add to My Stocks
$163.62 $2.65 (1.59%) AGN stock closing price Mar 20, 2018 (Closing)
Watch Robo Advisor Video of AGN Stock Analysis
Updated on : Mar 20, 2018
previous close
AGN 166.3 (0%)
S&P 500 2712.9 (0%)
Closing Price On: Mar 19, 2018
stock rating
RATING: ★★★★★★★★★★ (0/5)
Industry :
Medical-Generic Drugs
Sector :
5 Quarter Revenue
Revenue Growth
Compared to the industry
Operating Profit
Operating Margin:
Sector Average:
5 Quarter Net Profit
Net Margins
LTM Margin
Debt/Equity Ratio
Debt/Equity Ratio:
Compared to the industry
Cash Flow
Operating cash flow:
Net Income:
Dividend Yield
AGN dividend yield:
PE Valuation
FCF Margin
Operating Margins
Net Margins
High Debt Burden
Cash Flow
Rating: ★★★★★★★★★★ (0/5)
Relative Valuation
Industry PS :
Sector:   Medical.   *PE adjusted for one time items.
Other Metrics
Return on Invested Capital:
Return on Equity:
Free Cash Flow Margin:
Double Tap To Exit Full Screen

Allergan Stock Analysis

3479 7 2

Watch the robo advisor video of Allergan stock analysis on Amigobulls. Our AGN analysis video highlights revenue and profit trends along with other important metrics such as valuation to find what makes the stock attractive.

Note: Amigobulls stock rating is our opinion based on the historical performance of the company's fundamentals. It is not indicative of the future performance of the stock.

Allergan plc Ordinary Shares Stock Rating 3.2/5

We at Amigobulls use various financial measures including profit margins, revenue growth and dividends for AGN stock analysis. We also use relative valuation metrics like PE ratio and price to sales ratio for Allergan valuation analysis. Allergan stock rating encapsulates our opinion about the company based on the fundamentals.

Should you buy AGN stock?

  • AGN stock is trading at an earnings multiple of 10 which is better than the industry average of 24.
  • The company has a good Free Cash Flow (FCF) margin of 44.7%.

Should you sell AGN stock?

  • Allergan registered a negative operating margin of -37.2% (average) over the Trailing Twelve Months (TTM).
  • Allergan posted an average Net loss of -26.3% in the last twelve months.
  • With a debt/equity ratio of  0.35, Allergan is highly leveraged in comparison to Medical peers.
  • Cash flow from operations is 0.7 times net income which is a negative signal.
  • The company has a negative Return on Invested Capital of -2.2%, which is a red flag.
  • Allergan has a negative return on equity of -5.6%. This indicates that the firm is inefficient at generating profits.

Comments on this video and Allergan stock

Amigobulls Allergan stock analysis helps investors in understanding how the company's fundamentals have performed in the last few quarters. Fundamental analysis of a company is the most often used approach to find the intrinsic value of a stock.

Among the financials of the company, Allergan revenue growth along with the profit or net income give a clear picture of the financial health. Along with fundamentals, investors can utilize technical analysis to get a better idea about the price trend of Allergan stock.